|
1
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gianfagna F, De Feo E, van Duijn CM,
Ricciardi G and Boccia S: A systematic review of meta-analyses on
gene polymorphisms and gastric cancer risk. Curr Genomics.
9:361–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamilton JP and Meltzer SJ: A review of
the genomics of gastric cancer. Clin Gastroenterol Hepatol.
4:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Milne AN, Carneiro F, O'Morain C and
Offerhaus GJ: Nature meets nurture: Molecular genetics of gastric
cancer. Hum Genet. 126:615–628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saeki N, Ono H, Sakamoto H and Yoshida T:
Genetic factors related to gastric cancer susceptibility identified
using a genome-wide association study. Cancer Sci. 104:1–8. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshida T, Ono H, Kuchiba A, Saeki N and
Sakamoto H: Genome-wide germline analyses on cancer susceptibility
and GeMDBJ database: Gastric cancer as an example. Cancer Sci.
101:1582–1589. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bellec G, Dréano Y, Lozach P, Ménez JF and
Berthou F: Cytochrome P450 metabolic dealkylation of nine
N-nitrosodialkylamines by human liver microsomes. Carcinogenesis.
17:2029–2034. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ingelman-Sundberg M, Ronis MJ, Lindros KO,
Eliasson E and Zhukov A: Ethanol-inducible cytochrome P4502E1:
Regulation, enzymology and molecular biology. Alcohol Alcohol
Suppl. 2:131–139. 1994.PubMed/NCBI
|
|
11
|
Raucy JL, Kraner JC and Lasker JM:
Bioactivation of halogenated hydrocarbons by cytochrome P4502E1.
Crit Rev Toxicol. 23:1–20. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
La Vecchia C, D'Avanzo B, Airoldi L, Braga
C and Decarli A: Nitrosamine intake and gastric cancer risk. Eur J
Cancer Prev. 4:469–474. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agundez JA: Cytochrome P450 gene
polymorphism and cancer. Curr Drug Metab. 5:211–224. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uematsu F, Ikawa S, Kikuchi H, et al:
Restriction fragment length polymorphism of the human CYP2E1
(cytochrome P450IIE1) gene and susceptibility to lung cancer:
Possible relevance to low smoking exposure. Pharmacogenetics.
4:58–63. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayashi S, Watanabe J and Kawajiri K:
Genetic polymorphisms in the 5′-flanking region change
transcriptional regulation of the human cytochrome P450IIE1 gene. J
Biochem. 110:559–565. 1991.PubMed/NCBI
|
|
16
|
Uchimoto T, Itoga S, Nezu M, Sunaga M,
Tomonaga T and Nomura F: Role of the genetic polymorphisms in the
5′-flanking region for transcriptional regulation of the human
CYP2E1 gene. Alcohol Clin Exp Res. 31(Suppl 1): S36–S42. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang K, Li Y, Zhang Z, et al: The
PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer
risk: A meta-analysis based on 21 case-control studies. BMC Cancer.
10:5752010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Agudo A, Sala N, Pera G, et al: No
association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and
the risk of gastric adenocarcinoma in the European prospective
investigation into cancer and nutrition. Cancer Epidemiol
Biomarkers Prev. 15:1043–1045. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
González A, Ramírez V, Cuenca P and Sierra
R: Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and
GSTM1 in gastric cancer susceptibility. Rev Biol Trop. 52:591–600.
2004.(In Spanish). PubMed/NCBI
|
|
20
|
Boccia S, De Lauretis A, Gianfagna F, van
Duijn CM and Ricciardi G: CYP2E1PstI/RsaI polymorphism and
interaction with tobacco, alcohol and GSTs in gastric cancer
susceptibility: A meta-analysis of the literature. Carcinogenesis.
28:101–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai L, Yu SZ and Zhan ZF: Cytochrome P450
2E1 genetic polymorphism and gastric cancer in Changle, Fujian
Province. World J Gastroenterol. 7:792–795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao C, Takezaki T, Wu J, et al:
Interaction between cytochrome P-450 2E1 polymorphisms and
environmental factors with risk of esophageal and stomach cancers
in Chinese. Cancer Epidemiol Biomarkers Prev. 11:29–34. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Colombo J, Rossit AR, Caetano A, Borim AA,
Wornrath D and Silva AE: GSTT1, GSTM1 and CYP2E1 genetic
polymorphisms in gastric cancer and chronic gastritis in a
Brazilian population. World J Gastroenterol. 10:1240–1245.
2004.PubMed/NCBI
|
|
24
|
Darazy M, Balbaa M, Mugharbil A, et al:
CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to
colorectal and gastric cancer among Lebanese. Genet Test Mol
Biomarkers. 15:423–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ghoshal U, Tripathi S, Kumar S, et al:
Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2 and
CYP2E1 genes modulate susceptibility to gastric cancer in patients
with Helicobacter pylori infection. Gastric Cancer.
17:226–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nan HM, Song YJ, Yun HY, Park JS and Kim
H: Effects of dietary intake and genetic factors on
hypermethylation of the hMLH1 gene promoter in gastric cancer.
World J Gastroenterol. 11:3834–3841. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng J, Pan X, Yu J, et al: Functional
PstI/RsaI polymorphism in CYP2E1 is associated with the
development, progression and poor outcome of gastric cancer. PLoS
One. 7:e444782012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kato S, Onda M, Matsukura N, et al:
Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control
study of gastric cancer and liver disease. Pharmacogenetics.
5:S141–S144. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kato S, Onda M, Matsukura N, et al:
Genetic polymorphisms of the cancer related gene and
Helicobacter pylori infection in Japanese gastric cancer
patients. An age and gender matched case-control study. Cancer.
77(Suppl 8): S1654–S1661. 1996. View Article : Google Scholar
|
|
30
|
Kato S, Naito Z, Matsuda N, et al:
Localization of cytochrome P4502E1 enzyme in normal and cancerous
gastric mucosa and association with its genetic polymorphism in
unoperated and remnant stomach. J Nippon Med Sch. 78:224–234. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malakar M, Devi KR, Phukan RK, et al:
CYP2E1 genetic polymorphism with dietary, tobacco, alcohol habits,
H. pylori infection status and susceptibility to stomach
cancer in Mizoram, India. Asian Pac J Cancer Prev. 15:8815–8822.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malik MA, Upadhyay R, Mittal RD, Zargar
SA, Modi DR and Mittal B: Role of xenobiotic-metabolizing enzyme
gene polymorphisms and interactions with environmental factors in
susceptibility to gastric cancer in Kashmir Valley. J Gastrointest
Cancer. 40:26–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu MS, Chen CJ, Lin MT, et al: Genetic
polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1
and T1, and susceptibility to gastric carcinoma in Taiwan. Int J
Colorectal Dis. 17:338–343. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nishimoto IN, Hanaoka T, Sugimura H, et
al: Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil:
Case control studies of Japanese Brazilians and non-Japanese
Brazilians. Cancer Epidemiol Biomarkers Prev. 9:675–680.
2000.PubMed/NCBI
|
|
35
|
Park GT, Lee OY, Kwon SJ, et al: Analysis
of CYP2E1 polymorphism for the determination of genetic
susceptibility to gastric cancer in Koreans. J Gastroenterol
Hepatol. 18:1257–1263. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suzuki S, Muroishi Y, Nakanishi I and Oda
Y: Relationship between genetic polymorphisms of drug-metabolizing
enzymes (CYP1A1, CYP2E1, GSTM1 and NAT2), drinking habits,
histological subtypes, and p53 gene point mutations in Japanese
patients with gastric cancer. J Gastroenterol. 39:220–230. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsukino H, Kuroda Y, Qiu D, Nakao H, Imai
H and Katoh T: Effects of cytochrome P450 (CYP) 2A6 gene deletion
and CYP2E1 genotypes on gastric adenocarcinoma. Int J Cancer.
100:425–428. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Z and Xu L: Relationship between
cytochrome P450 2E1 gene polymorphism and gastric cancer
susceptibility. J Pract Med. 3380–3381. 2007.
|
|
39
|
Qian Y, Xu Y, Shen H, Yu R, Tan Y, Zhou L
and Niu J: Relationship between CYP2E1, GSTT1 genetic polymorphisms
and susceptibility to gastric cancer. China's primary health care.
18–20. 2001.
|
|
40
|
Qian Y, Xu Y, Shen H, Zhou L, Yu R, Niu J
and Tan Y: Relationship Between CYP2E1, GSTT1 Genetic Polymorphisms
and Susceptibility to Gastric Cancer. Chin J Prev Control Chron Non
Commun Dis. 107–109. 2003.
|
|
41
|
Wang Y, Jiang Y and Sun W: Effects of
genetic polymorphism of cytochrome P4502E1 on susceptibility to
gastric cancer. Chin J Publ Health. 664–665. 2005.
|
|
42
|
Yan S, Bai Z, Zhao J, Xie D and Wu J:
Correlation between genetic polymorphisms of CYP2E1 RsaI and
susceptibility of gastric cancer in Qinghai province. J Qinghai Med
Coll. 34:7–14. 2013.
|
|
43
|
Su Y, Zhenzhong B, Jian-xin Z, et al:
Correlation between genetic polymorphisms of CYP2E1 Dra I and
susceptibility of gastric cancer in Qinghai province. China Oncol.
23:273–278. 2013.
|
|
44
|
Ye M, Liu J, Zhou X and Deng C:
Association between CYE2E1 genotype and genetic susceptibility of
gastric cancer. J Fourth Mil Med Univ. 2265–2267. 2002.
|
|
45
|
Zhou J, Gao C, Takezaki T, Li Z, Wu J,
Ding J, Liu Y, Li S, Hu X, Kai H and Tajima K: Interaction between
polymorphisms in CYP2E1 Rsa I genotypes and lifestyle with risk of
stomach cancer. J Oncol. 9:285–288. 2003.
|
|
46
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Egger M, Smith Davey G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Munafò MR, Clark TG and Flint J: Assessing
publication bias in genetic association studies: Evidence from a
recent meta-analysis. Psychiatry Res. 129:39–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhuo W, Zhang L, Wang Y, Ling J, Zhu B and
Chen Z: CYP2E1 RsaI/PstI polymorphism and gastric cancer
susceptibility: Meta-analyses based on 24 case-control studies.
PLoS One. 7:e482652012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ruano-Ravina A, Pérez-Ríos M and
Barros-Dios JM: Population-based versus hospital-based controls:
Are they comparable? Gac Sanit. 22:609–613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Garte S, Gaspari L, Alexandrie AK, et al:
Metabolic gene polymorphism frequencies in control populations.
Cancer Epidemiol Biomarkers Prev. 10:1239–1248. 2001.PubMed/NCBI
|
|
54
|
Neafsey P, Ginsberg G, Hattis D, Johns DO,
Guyton KZ and Sonawane B: Genetic polymorphism in CYP2E1:
Population distribution of CYP2E1 activity. J Toxicol Environ
Health B Crit Rev. 12:362–388. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Stephens EA, Taylor JA, Kaplan N, et al:
Ethnic variation in the CYP2E1 gene: Polymorphism analysis of 695
African-Americans, European-Americans and Taiwanese.
Pharmacogenetics. 4:185–192. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Schmidt HM, Ha DM, Taylor EF, et al:
Variation in human genetic polymorphisms, their association with
Helicobacter pylori acquisition and gastric cancer in a
multi-ethnic country. J Gastroenterol Hepatol. 26:1725–1732. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Benowitz NL, Peng M and Jacob P III:
Effects of cigarette smoking and carbon monoxide on chlorzoxazone
and caffeine metabolism. Clin Pharmacol Ther. 74:468–474. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Murata M, Takayama K, Choi BC and Pak AW:
A nested case-control study on alcohol drinking, tobacco smoking,
and cancer. Cancer Detect Prev. 20:557–565. 1996.PubMed/NCBI
|
|
59
|
Masoudi M, Saadat I, Omidvari S and Saadat
M: Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of
gastric cancer. Mol Biol Rep. 36:781–784. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu X, Amos CI, Kemp BL, et al: Cytochrome
P450 2E1 DraI polymorphisms in lung cancer in minority populations.
Cancer Epidemiol Biomarkers Prev. 7:13–18. 1998.PubMed/NCBI
|
